A review of the literature suggests an increase in the expression of miR-204 in patients with AD compared to the control group based on publications reporting an increase in miR-204 in response to TXNIP in diabetic patients or decreased expression of GLP-1R by miR-204 [28]. Here, TXNIP is linked to Alzheimer disease.